Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 4.26913962 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.26913962 |
3 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.26195702 |
4 | aromatic amino acid family catabolic process (GO:0009074) | 4.19387278 |
5 | tryptophan catabolic process (GO:0006569) | 4.15751579 |
6 | indole-containing compound catabolic process (GO:0042436) | 4.15751579 |
7 | indolalkylamine catabolic process (GO:0046218) | 4.15751579 |
8 | presynaptic membrane assembly (GO:0097105) | 4.03752130 |
9 | behavioral response to nicotine (GO:0035095) | 4.03732827 |
10 | L-phenylalanine metabolic process (GO:0006558) | 3.87599396 |
11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.87599396 |
12 | tryptophan metabolic process (GO:0006568) | 3.84744523 |
13 | low-density lipoprotein particle remodeling (GO:0034374) | 3.74722661 |
14 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.70163086 |
15 | kynurenine metabolic process (GO:0070189) | 3.68557782 |
16 | regulation of cholesterol esterification (GO:0010872) | 3.67694609 |
17 | detection of calcium ion (GO:0005513) | 3.67575232 |
18 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.64175913 |
19 | bile acid biosynthetic process (GO:0006699) | 3.62773594 |
20 | presynaptic membrane organization (GO:0097090) | 3.60817118 |
21 | high-density lipoprotein particle remodeling (GO:0034375) | 3.56297135 |
22 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.56262507 |
23 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.52890566 |
24 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.51674491 |
25 | membrane depolarization during action potential (GO:0086010) | 3.43533807 |
26 | regulation of cell communication by electrical coupling (GO:0010649) | 3.42691058 |
27 | neuronal action potential (GO:0019228) | 3.39402385 |
28 | regulation of membrane repolarization (GO:0060306) | 3.39182211 |
29 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.34899239 |
30 | coenzyme catabolic process (GO:0009109) | 3.34489744 |
31 | glyoxylate metabolic process (GO:0046487) | 3.32301627 |
32 | relaxation of cardiac muscle (GO:0055119) | 3.30482961 |
33 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.30187487 |
34 | cellular ketone body metabolic process (GO:0046950) | 3.29168066 |
35 | oxaloacetate metabolic process (GO:0006107) | 3.28571603 |
36 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.24175019 |
37 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.22120313 |
38 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.14249647 |
39 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.14211136 |
40 | action potential (GO:0001508) | 3.12025294 |
41 | regulation of actin filament-based movement (GO:1903115) | 3.11612252 |
42 | succinate metabolic process (GO:0006105) | 3.11580602 |
43 | protein-lipid complex remodeling (GO:0034368) | 3.11306641 |
44 | macromolecular complex remodeling (GO:0034367) | 3.11306641 |
45 | plasma lipoprotein particle remodeling (GO:0034369) | 3.11306641 |
46 | reverse cholesterol transport (GO:0043691) | 3.10647665 |
47 | amine catabolic process (GO:0009310) | 3.10021600 |
48 | cellular biogenic amine catabolic process (GO:0042402) | 3.10021600 |
49 | NAD biosynthetic process (GO:0009435) | 3.06362603 |
50 | regulation of action potential (GO:0098900) | 3.05670719 |
51 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.05615323 |
52 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.04140587 |
53 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.03067964 |
54 | indolalkylamine metabolic process (GO:0006586) | 3.02647221 |
55 | dendritic spine morphogenesis (GO:0060997) | 3.01307790 |
56 | indole-containing compound metabolic process (GO:0042430) | 2.99566355 |
57 | potassium ion import (GO:0010107) | 2.99289211 |
58 | vocalization behavior (GO:0071625) | 2.97914112 |
59 | positive regulation of action potential (GO:0045760) | 2.97252654 |
60 | phospholipid efflux (GO:0033700) | 2.96366822 |
61 | neuron cell-cell adhesion (GO:0007158) | 2.96010460 |
62 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.95940786 |
63 | startle response (GO:0001964) | 2.95325916 |
64 | aromatic amino acid family metabolic process (GO:0009072) | 2.95173549 |
65 | bile acid metabolic process (GO:0008206) | 2.93890292 |
66 | NAD metabolic process (GO:0019674) | 2.93165081 |
67 | urea metabolic process (GO:0019627) | 2.92078310 |
68 | urea cycle (GO:0000050) | 2.92078310 |
69 | cell communication by electrical coupling (GO:0010644) | 2.92053827 |
70 | phospholipid homeostasis (GO:0055091) | 2.89116306 |
71 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.88227884 |
72 | glutamate secretion (GO:0014047) | 2.87650317 |
73 | serotonin metabolic process (GO:0042428) | 2.87038140 |
74 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.86832817 |
75 | glutamate receptor signaling pathway (GO:0007215) | 2.86418124 |
76 | cAMP catabolic process (GO:0006198) | 2.84653272 |
77 | glutamate metabolic process (GO:0006536) | 2.84117872 |
78 | alpha-amino acid catabolic process (GO:1901606) | 2.83715834 |
79 | cofactor catabolic process (GO:0051187) | 2.83470377 |
80 | regulation of fibrinolysis (GO:0051917) | 2.83312155 |
81 | complement activation, alternative pathway (GO:0006957) | 2.82843373 |
82 | cholesterol efflux (GO:0033344) | 2.82257594 |
83 | ketone body metabolic process (GO:1902224) | 2.82080287 |
84 | membrane repolarization during action potential (GO:0086011) | 2.81833831 |
85 | cellular potassium ion homeostasis (GO:0030007) | 2.81245191 |
86 | membrane repolarization (GO:0086009) | 2.81067603 |
87 | cardiac conduction (GO:0061337) | 2.80596349 |
88 | postsynaptic membrane organization (GO:0001941) | 2.78463382 |
89 | multicellular organismal signaling (GO:0035637) | 2.78043528 |
90 | cell communication involved in cardiac conduction (GO:0086065) | 2.77522502 |
91 | NADH metabolic process (GO:0006734) | 2.76474553 |
92 | transmission of nerve impulse (GO:0019226) | 2.76147710 |
93 | synaptic transmission, glutamatergic (GO:0035249) | 2.72513745 |
94 | regulation of relaxation of muscle (GO:1901077) | 2.72243785 |
95 | dicarboxylic acid catabolic process (GO:0043649) | 2.70963761 |
96 | tyrosine metabolic process (GO:0006570) | 2.70114934 |
97 | synaptic vesicle exocytosis (GO:0016079) | 2.70092247 |
98 | regulation of protein activation cascade (GO:2000257) | 2.68479490 |
99 | primary amino compound metabolic process (GO:1901160) | 2.68039670 |
100 | synaptic vesicle maturation (GO:0016188) | 2.66854203 |
101 | cyclic nucleotide catabolic process (GO:0009214) | 2.66843185 |
102 | nitrogen cycle metabolic process (GO:0071941) | 2.66819684 |
103 | gamma-aminobutyric acid transport (GO:0015812) | 2.66309852 |
104 | homocysteine metabolic process (GO:0050667) | 2.65755232 |
105 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.62711237 |
106 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.62497170 |
107 | lysine catabolic process (GO:0006554) | 2.62324933 |
108 | lysine metabolic process (GO:0006553) | 2.62324933 |
109 | aspartate family amino acid catabolic process (GO:0009068) | 2.61959071 |
110 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.61501302 |
111 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.61338967 |
112 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.61130209 |
113 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.60629772 |
114 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.59885068 |
115 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.59775874 |
116 | protein carboxylation (GO:0018214) | 2.59227898 |
117 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.59227898 |
118 | negative regulation of fibrinolysis (GO:0051918) | 2.58736656 |
119 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.58673530 |
120 | positive regulation of sodium ion transport (GO:0010765) | 2.57792245 |
121 | cellular amino acid catabolic process (GO:0009063) | 2.57279561 |
122 | membrane depolarization (GO:0051899) | 2.57092501 |
123 | behavioral response to cocaine (GO:0048148) | 2.55716383 |
124 | neuron-neuron synaptic transmission (GO:0007270) | 2.55694086 |
125 | short-chain fatty acid metabolic process (GO:0046459) | 2.53733955 |
126 | aldehyde catabolic process (GO:0046185) | 2.53313957 |
127 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.53090671 |
128 | female mating behavior (GO:0060180) | 2.52718362 |
129 | tricarboxylic acid cycle (GO:0006099) | 2.52265545 |
130 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.52093184 |
131 | protein localization to synapse (GO:0035418) | 2.51979490 |
132 | neuronal action potential propagation (GO:0019227) | 2.51792692 |
133 | cardiac muscle cell action potential (GO:0086001) | 2.51180449 |
134 | regulation of postsynaptic membrane potential (GO:0060078) | 2.50477928 |
135 | cellular glucuronidation (GO:0052695) | 2.49493950 |
136 | cardiac muscle contraction (GO:0060048) | 2.48815784 |
137 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.48676847 |
138 | regulation of activation of Janus kinase activity (GO:0010533) | 2.48485805 |
139 | uronic acid metabolic process (GO:0006063) | 2.47985535 |
140 | glucuronate metabolic process (GO:0019585) | 2.47985535 |
141 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.47719958 |
142 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.47719958 |
143 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.47609979 |
144 | cerebellar granule cell differentiation (GO:0021707) | 2.47033426 |
145 | alpha-linolenic acid metabolic process (GO:0036109) | 2.46730603 |
146 | regulation of glutamate secretion (GO:0014048) | 2.46565916 |
147 | amino-acid betaine metabolic process (GO:0006577) | 2.46351469 |
148 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.45818663 |
149 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.45207611 |
150 | DNA deamination (GO:0045006) | 2.44808141 |
151 | regulation of complement activation (GO:0030449) | 2.44744830 |
152 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.44085689 |
153 | 2-oxoglutarate metabolic process (GO:0006103) | 2.44013216 |
154 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.43566043 |
155 | regulation of triglyceride catabolic process (GO:0010896) | 2.42961217 |
156 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.42413155 |
157 | auditory behavior (GO:0031223) | 2.42303407 |
158 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.42159309 |
159 | response to pheromone (GO:0019236) | 2.41366191 |
160 | regulation of female receptivity (GO:0045924) | 2.41358344 |
161 | regulation of neurotransmitter uptake (GO:0051580) | 2.41212249 |
162 | benzene-containing compound metabolic process (GO:0042537) | 2.41048495 |
163 | positive regulation of meiosis (GO:0045836) | 2.40512636 |
164 | behavioral defense response (GO:0002209) | 2.39301836 |
165 | behavioral fear response (GO:0001662) | 2.39301836 |
166 | nucleobase catabolic process (GO:0046113) | 2.38828219 |
167 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.37506962 |
168 | regulation of striated muscle contraction (GO:0006942) | 2.37487140 |
169 | negative regulation of response to food (GO:0032096) | 2.37296702 |
170 | negative regulation of appetite (GO:0032099) | 2.37296702 |
171 | cardiac muscle hypertrophy (GO:0003300) | 2.36054859 |
172 | negative regulation of dendrite development (GO:2000171) | 2.35689944 |
173 | negative regulation of heart rate (GO:0010459) | 2.35323280 |
174 | neurotransmitter secretion (GO:0007269) | 2.33306853 |
175 | response to amphetamine (GO:0001975) | 2.33165818 |
176 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.32435644 |
177 | regulation of cardiac muscle contraction (GO:0055117) | 2.32268124 |
178 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.30681312 |
179 | proline transport (GO:0015824) | 2.30266430 |
180 | cellular potassium ion transport (GO:0071804) | 2.29827837 |
181 | potassium ion transmembrane transport (GO:0071805) | 2.29827837 |
182 | urinary tract smooth muscle contraction (GO:0014848) | 2.28364477 |
183 | reflex (GO:0060004) | 2.28274764 |
Rank | Gene Set | Z-score |
---|---|---|
1 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.10761106 |
2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.47070604 |
3 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.06649487 |
4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.81756871 |
5 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.79578662 |
6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.45711159 |
7 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.45598245 |
8 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.39339821 |
9 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.29222698 |
10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.28784681 |
11 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.24213956 |
12 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.23308535 |
13 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.16381806 |
14 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.12121840 |
15 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.05498504 |
16 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.02736223 |
17 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.01532853 |
18 | P300_19829295_ChIP-Seq_ESCs_Human | 2.00966751 |
19 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.85829123 |
20 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.84564723 |
21 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.82555529 |
22 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.82247115 |
23 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.78208290 |
24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.73975118 |
25 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.71905208 |
26 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.71561136 |
27 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.66792630 |
28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.61233797 |
29 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.58638985 |
30 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.55663784 |
31 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.54796672 |
32 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.54556107 |
33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.54528744 |
34 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.54320562 |
35 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.53451462 |
36 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.52514910 |
37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.51956588 |
38 | VDR_22108803_ChIP-Seq_LS180_Human | 1.49705823 |
39 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.49414765 |
40 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.48489177 |
41 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.48256771 |
42 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.46260052 |
43 | EWS_26573619_Chip-Seq_HEK293_Human | 1.46006183 |
44 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.45426777 |
45 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.44267028 |
46 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.43090106 |
47 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.43090106 |
48 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.42689071 |
49 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.41419201 |
50 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.39713165 |
51 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.39680478 |
52 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.39236135 |
53 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.37417396 |
54 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.36592454 |
55 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.36379047 |
56 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.35767755 |
57 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.35346258 |
58 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.34714720 |
59 | AR_25329375_ChIP-Seq_VCAP_Human | 1.34189118 |
60 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.33652356 |
61 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.33652356 |
62 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.32222056 |
63 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.30980585 |
64 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.30835204 |
65 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.30835204 |
66 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.30219850 |
67 | FUS_26573619_Chip-Seq_HEK293_Human | 1.29117415 |
68 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.28949439 |
69 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.27923039 |
70 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.26835049 |
71 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.26667196 |
72 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24819772 |
73 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.24598857 |
74 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.24589335 |
75 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.24566433 |
76 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.24109354 |
77 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.23642295 |
78 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.23239680 |
79 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.23206359 |
80 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.22481442 |
81 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.21089657 |
82 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.20544922 |
83 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.20183485 |
84 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.19282064 |
85 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.18915020 |
86 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.18915020 |
87 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.18071305 |
88 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.17887239 |
89 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.16948826 |
90 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.16782229 |
91 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.15046538 |
92 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.14196657 |
93 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.13945025 |
94 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.13258994 |
95 | STAT3_23295773_ChIP-Seq_U87_Human | 1.12955777 |
96 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.11383021 |
97 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.10943175 |
98 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.10852633 |
99 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.10726324 |
100 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.10077037 |
101 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.09786771 |
102 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.09657315 |
103 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.08565693 |
104 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.08099122 |
105 | TCF4_23295773_ChIP-Seq_U87_Human | 1.07887964 |
106 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07728555 |
107 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.05697519 |
108 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.04964696 |
109 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.04728694 |
110 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.04653824 |
111 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.04364062 |
112 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.03851143 |
113 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03263910 |
114 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.03130866 |
115 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.03002898 |
116 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.02991769 |
117 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02610918 |
118 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.02584666 |
119 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.02473629 |
120 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.02072637 |
121 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.01276338 |
122 | KDM2B_26808549_Chip-Seq_REH_Human | 1.01170194 |
123 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.00517418 |
124 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99617448 |
125 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.99051873 |
126 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.97684580 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 4.44508427 |
2 | MP0003880_abnormal_central_pattern | 3.93380471 |
3 | MP0005085_abnormal_gallbladder_physiolo | 3.91233854 |
4 | MP0005360_urolithiasis | 3.75671546 |
5 | MP0005365_abnormal_bile_salt | 3.54638719 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.52949357 |
7 | MP0002876_abnormal_thyroid_physiology | 2.88094133 |
8 | MP0004859_abnormal_synaptic_plasticity | 2.48529552 |
9 | MP0009745_abnormal_behavioral_response | 2.46667563 |
10 | MP0000569_abnormal_digit_pigmentation | 2.36359511 |
11 | MP0009046_muscle_twitch | 2.35673067 |
12 | MP0003195_calcinosis | 2.26651055 |
13 | MP0002837_dystrophic_cardiac_calcinosis | 2.26187932 |
14 | MP0002064_seizures | 2.22381096 |
15 | MP0003635_abnormal_synaptic_transmissio | 2.20498521 |
16 | MP0008877_abnormal_DNA_methylation | 2.18063317 |
17 | MP0010329_abnormal_lipoprotein_level | 2.16201292 |
18 | MP0005423_abnormal_somatic_nervous | 2.10738733 |
19 | MP0001968_abnormal_touch/_nociception | 2.07546166 |
20 | MP0002736_abnormal_nociception_after | 1.99412835 |
21 | MP0005646_abnormal_pituitary_gland | 1.98209764 |
22 | MP0002063_abnormal_learning/memory/cond | 1.94699291 |
23 | MP0002102_abnormal_ear_morphology | 1.86529101 |
24 | MP0001986_abnormal_taste_sensitivity | 1.85309035 |
25 | MP0002822_catalepsy | 1.85258890 |
26 | MP0002638_abnormal_pupillary_reflex | 1.82931520 |
27 | MP0002272_abnormal_nervous_system | 1.82866653 |
28 | MP0004885_abnormal_endolymph | 1.80784590 |
29 | MP0002572_abnormal_emotion/affect_behav | 1.79380529 |
30 | MP0009697_abnormal_copulation | 1.77641525 |
31 | MP0003806_abnormal_nucleotide_metabolis | 1.77141655 |
32 | MP0004084_abnormal_cardiac_muscle | 1.76928914 |
33 | MP0002138_abnormal_hepatobiliary_system | 1.71752062 |
34 | MP0003252_abnormal_bile_duct | 1.71616962 |
35 | * MP0005332_abnormal_amino_acid | 1.61989959 |
36 | MP0001501_abnormal_sleep_pattern | 1.61093649 |
37 | MP0001984_abnormal_olfaction | 1.60689346 |
38 | MP0004510_myositis | 1.58790602 |
39 | MP0000372_irregular_coat_pigmentation | 1.58708118 |
40 | MP0001486_abnormal_startle_reflex | 1.54412459 |
41 | MP0009780_abnormal_chondrocyte_physiolo | 1.54074468 |
42 | MP0003137_abnormal_impulse_conducting | 1.53255708 |
43 | MP0004270_analgesia | 1.51017948 |
44 | MP0003646_muscle_fatigue | 1.47677281 |
45 | MP0003191_abnormal_cellular_cholesterol | 1.45352848 |
46 | MP0003879_abnormal_hair_cell | 1.45089822 |
47 | MP0009840_abnormal_foam_cell | 1.42935578 |
48 | MP0004142_abnormal_muscle_tone | 1.40026829 |
49 | MP0002067_abnormal_sensory_capabilities | 1.36331867 |
50 | MP0006072_abnormal_retinal_apoptosis | 1.36185249 |
51 | MP0002909_abnormal_adrenal_gland | 1.36143972 |
52 | MP0004145_abnormal_muscle_electrophysio | 1.34059028 |
53 | MP0005253_abnormal_eye_physiology | 1.30480326 |
54 | MP0002735_abnormal_chemical_nociception | 1.27898304 |
55 | MP0001440_abnormal_grooming_behavior | 1.27565235 |
56 | MP0002163_abnormal_gland_morphology | 1.26820200 |
57 | MP0005535_abnormal_body_temperature | 1.26243520 |
58 | MP0005084_abnormal_gallbladder_morpholo | 1.25170813 |
59 | MP0005083_abnormal_biliary_tract | 1.23990683 |
60 | MP0002118_abnormal_lipid_homeostasis | 1.23782315 |
61 | MP0006035_abnormal_mitochondrial_morpho | 1.22666323 |
62 | MP0003121_genomic_imprinting | 1.21578338 |
63 | MP0008775_abnormal_heart_ventricle | 1.21574614 |
64 | MP0005174_abnormal_tail_pigmentation | 1.20825955 |
65 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.19997645 |
66 | MP0001485_abnormal_pinna_reflex | 1.19864765 |
67 | MP0005379_endocrine/exocrine_gland_phen | 1.18451425 |
68 | MP0002734_abnormal_mechanical_nocicepti | 1.18088779 |
69 | MP0004130_abnormal_muscle_cell | 1.16638690 |
70 | MP0001764_abnormal_homeostasis | 1.16397464 |
71 | MP0005386_behavior/neurological_phenoty | 1.15030608 |
72 | MP0004924_abnormal_behavior | 1.15030608 |
73 | MP0000631_abnormal_neuroendocrine_gland | 1.14892724 |
74 | MP0001905_abnormal_dopamine_level | 1.12701273 |
75 | MP0006276_abnormal_autonomic_nervous | 1.12518396 |
76 | MP0004043_abnormal_pH_regulation | 1.11098990 |
77 | MP0000778_abnormal_nervous_system | 1.09699435 |
78 | MP0003136_yellow_coat_color | 1.09109034 |
79 | MP0004019_abnormal_vitamin_homeostasis | 1.08449236 |
80 | MP0003690_abnormal_glial_cell | 1.07731657 |
81 | MP0006036_abnormal_mitochondrial_physio | 1.06991453 |
82 | MP0008874_decreased_physiological_sensi | 1.06761630 |
83 | MP0003787_abnormal_imprinting | 1.06072222 |
84 | MP0003283_abnormal_digestive_organ | 1.05590396 |
85 | MP0001529_abnormal_vocalization | 1.03991940 |
86 | MP0001666_abnormal_nutrient_absorption | 1.03401552 |
87 | MP0008872_abnormal_physiological_respon | 1.03123816 |
88 | MP0002693_abnormal_pancreas_physiology | 1.01890355 |
89 | MP0004742_abnormal_vestibular_system | 1.01542431 |
90 | MP0001502_abnormal_circadian_rhythm | 0.99746641 |
91 | MP0005075_abnormal_melanosome_morpholog | 0.99361241 |
92 | MP0004036_abnormal_muscle_relaxation | 0.98732876 |
93 | MP0002254_reproductive_system_inflammat | 0.97115440 |
94 | MP0002229_neurodegeneration | 0.96707025 |
95 | MP0004215_abnormal_myocardial_fiber | 0.96586285 |
96 | MP0009764_decreased_sensitivity_to | 0.95057546 |
97 | MP0003633_abnormal_nervous_system | 0.94598478 |
98 | MP0005319_abnormal_enzyme/_coenzyme | 0.94574252 |
99 | MP0003868_abnormal_feces_composition | 0.93141623 |
100 | MP0003122_maternal_imprinting | 0.92857576 |
101 | MP0000604_amyloidosis | 0.90210542 |
102 | MP0002160_abnormal_reproductive_system | 0.89713255 |
103 | MP0001346_abnormal_lacrimal_gland | 0.89636197 |
104 | MP0005620_abnormal_muscle_contractility | 0.89017980 |
105 | MP0004147_increased_porphyrin_level | 0.88304113 |
106 | MP0001835_abnormal_antigen_presentation | 0.88126738 |
107 | MP0005451_abnormal_body_composition | 0.87059154 |
108 | MP0010386_abnormal_urinary_bladder | 0.86794963 |
109 | MP0003329_amyloid_beta_deposits | 0.85649235 |
110 | MP0003011_delayed_dark_adaptation | 0.85251964 |
111 | MP0005389_reproductive_system_phenotype | 0.84608950 |
112 | MP0001963_abnormal_hearing_physiology | 0.83849658 |
113 | MP0002184_abnormal_innervation | 0.83194248 |
114 | MP0008995_early_reproductive_senescence | 0.82891707 |
115 | MP0000609_abnormal_liver_physiology | 0.82810867 |
116 | MP0002882_abnormal_neuron_morphology | 0.82662482 |
117 | MP0003631_nervous_system_phenotype | 0.82636555 |
118 | MP0001188_hyperpigmentation | 0.81803580 |
119 | MP0002928_abnormal_bile_duct | 0.80224810 |
120 | MP0009785_altered_susceptibility_to | 0.80118021 |
121 | MP0002557_abnormal_social/conspecific_i | 0.78683772 |
122 | MP0004133_heterotaxia | 0.78538665 |
123 | MP0005171_absent_coat_pigmentation | 0.78425797 |
124 | MP0001970_abnormal_pain_threshold | 0.77981602 |
125 | MP0005167_abnormal_blood-brain_barrier | 0.77359973 |
126 | MP0000955_abnormal_spinal_cord | 0.77048820 |
127 | MP0001544_abnormal_cardiovascular_syste | 0.75201921 |
128 | MP0005385_cardiovascular_system_phenoty | 0.75201921 |
129 | MP0003183_abnormal_peptide_metabolism | 0.74676689 |
130 | MP0005310_abnormal_salivary_gland | 0.73749875 |
131 | MP0002066_abnormal_motor_capabilities/c | 0.73233555 |
132 | MP0000749_muscle_degeneration | 0.72394078 |
133 | MP0008569_lethality_at_weaning | 0.71649211 |
134 | MP0002332_abnormal_exercise_endurance | 0.71486065 |
135 | MP0004085_abnormal_heartbeat | 0.71411460 |
136 | MP0002733_abnormal_thermal_nociception | 0.71090341 |
137 | MP0001944_abnormal_pancreas_morphology | 0.70668001 |
138 | MP0000026_abnormal_inner_ear | 0.70457077 |
139 | MP0002078_abnormal_glucose_homeostasis | 0.69892461 |
140 | MP0005551_abnormal_eye_electrophysiolog | 0.67899454 |
141 | MP0000230_abnormal_systemic_arterial | 0.66869420 |
142 | MP0005448_abnormal_energy_balance | 0.66801005 |
143 | MP0002972_abnormal_cardiac_muscle | 0.66398218 |
144 | MP0005645_abnormal_hypothalamus_physiol | 0.65867685 |
145 | MP0004484_altered_response_of | 0.65688991 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 5.59453344 |
2 | Hyperventilation (HP:0002883) | 5.39924896 |
3 | Prolonged partial thromboplastin time (HP:0003645) | 4.27294473 |
4 | Epileptic encephalopathy (HP:0200134) | 4.07698269 |
5 | Atonic seizures (HP:0010819) | 3.88490292 |
6 | Intrahepatic cholestasis (HP:0001406) | 3.83648015 |
7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.78858058 |
8 | Febrile seizures (HP:0002373) | 3.72924573 |
9 | Deep venous thrombosis (HP:0002625) | 3.56156579 |
10 | Syncope (HP:0001279) | 3.55055357 |
11 | Progressive cerebellar ataxia (HP:0002073) | 3.40061462 |
12 | Bundle branch block (HP:0011710) | 3.37956563 |
13 | Hypobetalipoproteinemia (HP:0003563) | 3.35810718 |
14 | Cerebral edema (HP:0002181) | 3.23183910 |
15 | Congenital stationary night blindness (HP:0007642) | 3.18519963 |
16 | Acute necrotizing encephalopathy (HP:0006965) | 3.16019235 |
17 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.09936791 |
18 | Acute encephalopathy (HP:0006846) | 3.09682484 |
19 | Atrial fibrillation (HP:0005110) | 3.09480917 |
20 | Sudden death (HP:0001699) | 3.09162655 |
21 | Joint hemorrhage (HP:0005261) | 3.07084288 |
22 | Hyperlipoproteinemia (HP:0010980) | 3.06354356 |
23 | Limb dystonia (HP:0002451) | 3.05932182 |
24 | Pancreatic cysts (HP:0001737) | 3.04113419 |
25 | Conjugated hyperbilirubinemia (HP:0002908) | 2.97591643 |
26 | Primary atrial arrhythmia (HP:0001692) | 2.95051387 |
27 | Xanthomatosis (HP:0000991) | 2.91810314 |
28 | Fair hair (HP:0002286) | 2.89465840 |
29 | Nephronophthisis (HP:0000090) | 2.85130829 |
30 | Absence seizures (HP:0002121) | 2.84912806 |
31 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.83253719 |
32 | Abnormal hair whorl (HP:0010721) | 2.82098575 |
33 | Progressive macrocephaly (HP:0004481) | 2.79872077 |
34 | Pancreatic fibrosis (HP:0100732) | 2.79868462 |
35 | Supraventricular tachycardia (HP:0004755) | 2.77940517 |
36 | Abnormality of methionine metabolism (HP:0010901) | 2.77017510 |
37 | Abnormality of the renal cortex (HP:0011035) | 2.75309301 |
38 | True hermaphroditism (HP:0010459) | 2.72025170 |
39 | Molar tooth sign on MRI (HP:0002419) | 2.71998640 |
40 | Abnormality of midbrain morphology (HP:0002418) | 2.71998640 |
41 | Complement deficiency (HP:0004431) | 2.71826317 |
42 | Focal seizures (HP:0007359) | 2.70519141 |
43 | Dialeptic seizures (HP:0011146) | 2.68251922 |
44 | Ketosis (HP:0001946) | 2.65968603 |
45 | Supraventricular arrhythmia (HP:0005115) | 2.65739269 |
46 | Mitochondrial inheritance (HP:0001427) | 2.65106462 |
47 | Pheochromocytoma (HP:0002666) | 2.65045843 |
48 | Neuroendocrine neoplasm (HP:0100634) | 2.62597764 |
49 | Hemiparesis (HP:0001269) | 2.61273481 |
50 | Ventricular fibrillation (HP:0001663) | 2.59804012 |
51 | Hepatocellular necrosis (HP:0001404) | 2.59559415 |
52 | Myokymia (HP:0002411) | 2.58316653 |
53 | Prolonged QT interval (HP:0001657) | 2.57826387 |
54 | Type II lissencephaly (HP:0007260) | 2.57706218 |
55 | Hyperammonemia (HP:0001987) | 2.55590662 |
56 | Hepatic necrosis (HP:0002605) | 2.55240638 |
57 | Agitation (HP:0000713) | 2.54774431 |
58 | Hyperglycinemia (HP:0002154) | 2.54184221 |
59 | Increased CSF lactate (HP:0002490) | 2.53952533 |
60 | Abnormality of glycolysis (HP:0004366) | 2.52118543 |
61 | Increased serum pyruvate (HP:0003542) | 2.52118543 |
62 | Generalized tonic-clonic seizures (HP:0002069) | 2.51780612 |
63 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.49792704 |
64 | Epidermoid cyst (HP:0200040) | 2.48479130 |
65 | Blue irides (HP:0000635) | 2.44761783 |
66 | Abnormal EKG (HP:0003115) | 2.43367997 |
67 | Abnormality of the renal medulla (HP:0100957) | 2.41212097 |
68 | Abnormal drinking behavior (HP:0030082) | 2.40321556 |
69 | Polydipsia (HP:0001959) | 2.40321556 |
70 | Fat malabsorption (HP:0002630) | 2.37248021 |
71 | Lethargy (HP:0001254) | 2.33681891 |
72 | Spontaneous abortion (HP:0005268) | 2.33452084 |
73 | Hypolipoproteinemia (HP:0010981) | 2.33106639 |
74 | Drooling (HP:0002307) | 2.32989063 |
75 | Left ventricular hypertrophy (HP:0001712) | 2.32933897 |
76 | Medial flaring of the eyebrow (HP:0010747) | 2.32801288 |
77 | Increased IgM level (HP:0003496) | 2.32151965 |
78 | Genetic anticipation (HP:0003743) | 2.32133889 |
79 | Ketoacidosis (HP:0001993) | 2.26248317 |
80 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.25234624 |
81 | Lactic acidosis (HP:0003128) | 2.23857351 |
82 | Metabolic acidosis (HP:0001942) | 2.21462043 |
83 | Excessive salivation (HP:0003781) | 2.20752735 |
84 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.18415236 |
85 | Status epilepticus (HP:0002133) | 2.17870737 |
86 | Decreased circulating renin level (HP:0003351) | 2.17535851 |
87 | Generalized hypopigmentation of hair (HP:0011358) | 2.15764966 |
88 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.15584878 |
89 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.14876158 |
90 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.14809745 |
91 | Broad-based gait (HP:0002136) | 2.14623682 |
92 | Abnormal gallbladder morphology (HP:0012437) | 2.14595279 |
93 | Gait imbalance (HP:0002141) | 2.13968164 |
94 | Abnormality of the common coagulation pathway (HP:0010990) | 2.13794898 |
95 | Hyperglycinuria (HP:0003108) | 2.12144026 |
96 | Oligomenorrhea (HP:0000876) | 2.11758350 |
97 | Absent speech (HP:0001344) | 2.11697146 |
98 | Cholecystitis (HP:0001082) | 2.11657453 |
99 | Abnormal gallbladder physiology (HP:0012438) | 2.11657453 |
100 | Abnormality of serum amino acid levels (HP:0003112) | 2.10420888 |
101 | Large for gestational age (HP:0001520) | 2.10252913 |
102 | Methylmalonic acidemia (HP:0002912) | 2.07895623 |
103 | Abnormality of glycine metabolism (HP:0010895) | 2.06870960 |
104 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.06870960 |
105 | Cholelithiasis (HP:0001081) | 2.06839311 |
106 | Hemiplegia (HP:0002301) | 2.03641993 |
107 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.02604414 |
108 | Abolished electroretinogram (ERG) (HP:0000550) | 2.02463281 |
109 | Epileptiform EEG discharges (HP:0011182) | 2.02143183 |
110 | Hypochromic microcytic anemia (HP:0004840) | 2.01902466 |
111 | Mitral stenosis (HP:0001718) | 1.99749616 |
112 | Hyperbilirubinemia (HP:0002904) | 1.99162283 |
113 | Clumsiness (HP:0002312) | 1.97876734 |
114 | Congenital sensorineural hearing impairment (HP:0008527) | 1.97215303 |
115 | Inability to walk (HP:0002540) | 1.95749422 |
116 | Ventricular arrhythmia (HP:0004308) | 1.95607056 |
117 | Polyphagia (HP:0002591) | 1.94946917 |
118 | Chronic hepatic failure (HP:0100626) | 1.93771479 |
119 | Protruding tongue (HP:0010808) | 1.93604744 |
120 | Hypoglycemic coma (HP:0001325) | 1.93201607 |
121 | Heart block (HP:0012722) | 1.92719089 |
122 | Poor suck (HP:0002033) | 1.92389173 |
123 | Optic disc pallor (HP:0000543) | 1.92284935 |
124 | Attenuation of retinal blood vessels (HP:0007843) | 1.91585857 |
125 | Systemic lupus erythematosus (HP:0002725) | 1.91444988 |
126 | Gaze-evoked nystagmus (HP:0000640) | 1.91368925 |
127 | Steatorrhea (HP:0002570) | 1.90633259 |
128 | Hypoalphalipoproteinemia (HP:0003233) | 1.89643005 |
129 | 3-Methylglutaconic aciduria (HP:0003535) | 1.88303790 |
130 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.88030527 |
131 | Dicarboxylic aciduria (HP:0003215) | 1.88030527 |
132 | Hypothermia (HP:0002045) | 1.87566842 |
133 | Acute hepatic failure (HP:0006554) | 1.86641601 |
134 | Renal cortical cysts (HP:0000803) | 1.86022731 |
135 | Poor eye contact (HP:0000817) | 1.85322787 |
136 | Decreased central vision (HP:0007663) | 1.83910882 |
137 | Anxiety (HP:0000739) | 1.83760652 |
138 | Abnormality of the intrinsic pathway (HP:0010989) | 1.82943673 |
139 | Hypercholesterolemia (HP:0003124) | 1.82103162 |
140 | Thyroiditis (HP:0100646) | 1.81990060 |
141 | Sensorimotor neuropathy (HP:0007141) | 1.81446513 |
142 | Stomach cancer (HP:0012126) | 1.81445927 |
143 | Cerebral hemorrhage (HP:0001342) | 1.81088372 |
144 | Hypsarrhythmia (HP:0002521) | 1.80386296 |
145 | EEG with generalized epileptiform discharges (HP:0011198) | 1.80269054 |
146 | Abnormality of binocular vision (HP:0011514) | 1.80087092 |
147 | Diplopia (HP:0000651) | 1.80087092 |
148 | Calf muscle hypertrophy (HP:0008981) | 1.80048646 |
149 | Congenital primary aphakia (HP:0007707) | 1.79178486 |
150 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.78885283 |
151 | Progressive inability to walk (HP:0002505) | 1.78589472 |
152 | Leukodystrophy (HP:0002415) | 1.77426978 |
153 | Cystic liver disease (HP:0006706) | 1.76966682 |
154 | Male pseudohermaphroditism (HP:0000037) | 1.76630664 |
155 | Impaired social interactions (HP:0000735) | 1.76370631 |
156 | Abnormal social behavior (HP:0012433) | 1.76370631 |
157 | Pachygyria (HP:0001302) | 1.75983914 |
158 | Lissencephaly (HP:0001339) | 1.75848995 |
159 | Furrowed tongue (HP:0000221) | 1.75523760 |
160 | Abnormal eating behavior (HP:0100738) | 1.74139591 |
161 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.72083451 |
162 | Dysdiadochokinesis (HP:0002075) | 1.70918387 |
163 | Papilledema (HP:0001085) | 1.70050177 |
164 | Polyuria (HP:0000103) | 1.69826612 |
165 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.68711442 |
166 | Abnormality of alanine metabolism (HP:0010916) | 1.68711442 |
167 | Hyperalaninemia (HP:0003348) | 1.68711442 |
168 | Nephrogenic diabetes insipidus (HP:0009806) | 1.68638632 |
169 | Action tremor (HP:0002345) | 1.66834033 |
170 | Congenital, generalized hypertrichosis (HP:0004540) | 1.65578207 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CASK | 6.66571799 |
2 | FRK | 5.07879745 |
3 | MARK1 | 3.14978823 |
4 | EPHA4 | 2.92090037 |
5 | MAP2K7 | 2.89404446 |
6 | MAP3K12 | 2.78980020 |
7 | AKT3 | 2.72764386 |
8 | PRPF4B | 2.44951074 |
9 | MAP3K14 | 2.35437135 |
10 | DAPK2 | 2.32153722 |
11 | NTRK3 | 2.27695792 |
12 | BMPR2 | 2.16497632 |
13 | PAK3 | 2.07228033 |
14 | MAP3K4 | 2.06038355 |
15 | MAP2K4 | 2.02718967 |
16 | CDK19 | 2.01800089 |
17 | INSRR | 2.00299707 |
18 | PLK2 | 1.99465488 |
19 | WNK3 | 1.97553536 |
20 | CCNB1 | 1.92528646 |
21 | SIK3 | 1.88986232 |
22 | ACVR1B | 1.76799673 |
23 | OXSR1 | 1.70582219 |
24 | MYLK | 1.64688260 |
25 | SGK2 | 1.63472615 |
26 | BCR | 1.60960287 |
27 | GRK1 | 1.59836145 |
28 | RIPK4 | 1.58093333 |
29 | MAP3K13 | 1.54945559 |
30 | DAPK1 | 1.51368803 |
31 | BCKDK | 1.36809398 |
32 | MAP4K2 | 1.36553161 |
33 | WNK4 | 1.36242057 |
34 | TLK1 | 1.34545315 |
35 | SGK223 | 1.32945898 |
36 | SGK494 | 1.32945898 |
37 | ARAF | 1.30701189 |
38 | TNIK | 1.21694062 |
39 | PDK3 | 1.18499595 |
40 | PDK4 | 1.18499595 |
41 | CAMKK2 | 1.17552632 |
42 | OBSCN | 1.17248818 |
43 | PNCK | 1.14829143 |
44 | GRK7 | 1.12195861 |
45 | FGFR2 | 1.10583698 |
46 | ITK | 1.10477414 |
47 | GRK5 | 1.07660305 |
48 | PRKCE | 1.05597689 |
49 | ADRBK2 | 1.05514273 |
50 | SGK3 | 1.04039198 |
51 | CAMK2A | 1.03477202 |
52 | PTK2B | 1.00795575 |
53 | PKN1 | 0.98089275 |
54 | ERBB4 | 0.94798453 |
55 | STK11 | 0.90756944 |
56 | PIK3CA | 0.90577570 |
57 | PRKCG | 0.89873941 |
58 | BLK | 0.88898769 |
59 | CAMK2B | 0.85427148 |
60 | MUSK | 0.84874862 |
61 | NUAK1 | 0.84166117 |
62 | MAPK13 | 0.83935423 |
63 | UHMK1 | 0.83009387 |
64 | PINK1 | 0.82183669 |
65 | EPHA3 | 0.81936557 |
66 | JAK1 | 0.81523906 |
67 | ERBB3 | 0.76726278 |
68 | BRAF | 0.76451326 |
69 | TYK2 | 0.76175962 |
70 | NEK6 | 0.76066363 |
71 | MINK1 | 0.75406719 |
72 | CAMK2G | 0.75179741 |
73 | MAP4K1 | 0.75037494 |
74 | CSNK1G2 | 0.75030929 |
75 | PDK2 | 0.73973016 |
76 | KIT | 0.73913166 |
77 | TEC | 0.72769174 |
78 | TSSK6 | 0.71580267 |
79 | DYRK2 | 0.70502515 |
80 | PRKCQ | 0.69571807 |
81 | PRKCH | 0.69434570 |
82 | MAPK7 | 0.68781178 |
83 | DMPK | 0.67752728 |
84 | MAPK15 | 0.65977045 |
85 | PAK6 | 0.64988436 |
86 | BMPR1B | 0.63978786 |
87 | MAPK12 | 0.62345415 |
88 | TNK2 | 0.61361665 |
89 | STK24 | 0.60139103 |
90 | SGK1 | 0.60137281 |
91 | ZAK | 0.58015405 |
92 | CAMK2D | 0.57804864 |
93 | TXK | 0.56933017 |
94 | DAPK3 | 0.55556141 |
95 | DYRK1A | 0.54571468 |
96 | PRKD1 | 0.53906702 |
97 | IKBKE | 0.53782904 |
98 | CDK5 | 0.52943724 |
99 | STK16 | 0.51542084 |
100 | CAMK4 | 0.50946390 |
101 | PRKAA1 | 0.50711094 |
102 | NLK | 0.49474898 |
103 | STK39 | 0.49318935 |
104 | FGFR3 | 0.47832898 |
105 | IKBKB | 0.47598788 |
106 | SYK | 0.45899099 |
107 | CAMKK1 | 0.45140051 |
108 | FGR | 0.44557772 |
109 | RPS6KA5 | 0.44491252 |
110 | LYN | 0.43638843 |
111 | ADRBK1 | 0.43294015 |
112 | NTRK2 | 0.42727319 |
113 | PRKACA | 0.42582621 |
114 | MAP3K7 | 0.42450317 |
115 | YES1 | 0.42414897 |
116 | IRAK1 | 0.41545806 |
117 | PHKG1 | 0.41477391 |
118 | PHKG2 | 0.41477391 |
119 | FES | 0.41341722 |
120 | RPS6KA3 | 0.41337779 |
121 | NME1 | 0.40767325 |
122 | TAOK3 | 0.40757613 |
123 | MAPK4 | 0.40744328 |
124 | PRKAA2 | 0.39214719 |
125 | SIK2 | 0.39083052 |
126 | CDK3 | 0.38785774 |
127 | MAP2K6 | 0.38732548 |
128 | CAMK1 | 0.36771413 |
129 | PDK1 | 0.35077484 |
130 | PDPK1 | 0.34823630 |
131 | PRKCZ | 0.34374909 |
132 | IRAK4 | 0.32316639 |
133 | PRKG1 | 0.32160159 |
134 | TBK1 | 0.31170930 |
135 | PRKCA | 0.30976034 |
136 | MAP3K9 | 0.29775587 |
137 | PRKACG | 0.29506156 |
138 | TIE1 | 0.28801108 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.47898426 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.29998617 |
3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.45624155 |
4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.25052443 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.25018846 |
6 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.10899614 |
7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.10612109 |
8 | Phototransduction_Homo sapiens_hsa04744 | 2.09640727 |
9 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.01097931 |
10 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.89149940 |
11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.88910898 |
12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.87707100 |
13 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.87207218 |
14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.81823361 |
15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.81706006 |
16 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.78465355 |
17 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.78381082 |
18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.77615912 |
19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.75558535 |
20 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.74161099 |
21 | Peroxisome_Homo sapiens_hsa04146 | 1.72442402 |
22 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.63098220 |
23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.62805545 |
24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.61674796 |
25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.60563808 |
26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.60197598 |
27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.57159412 |
28 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.55293066 |
29 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.52160241 |
30 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.51536348 |
31 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.49194389 |
32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.48986311 |
33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.48582690 |
34 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.44802285 |
35 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.38535075 |
36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.38311897 |
37 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.37963916 |
38 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.37436104 |
39 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.36144594 |
40 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.35260135 |
41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.33398848 |
42 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.31145073 |
43 | GABAergic synapse_Homo sapiens_hsa04727 | 1.28989606 |
44 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.23523436 |
45 | Morphine addiction_Homo sapiens_hsa05032 | 1.22997174 |
46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.22613995 |
47 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.21274341 |
48 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.18041561 |
49 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.17627526 |
50 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.17181623 |
51 | Histidine metabolism_Homo sapiens_hsa00340 | 1.16559208 |
52 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.15698281 |
53 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.14514846 |
54 | Parkinsons disease_Homo sapiens_hsa05012 | 1.13934834 |
55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.13337254 |
56 | Allograft rejection_Homo sapiens_hsa05330 | 1.10522722 |
57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.10058689 |
58 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.08856936 |
59 | Alzheimers disease_Homo sapiens_hsa05010 | 1.05687117 |
60 | Retinol metabolism_Homo sapiens_hsa00830 | 1.05150833 |
61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.03677197 |
62 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.01174566 |
63 | Carbon metabolism_Homo sapiens_hsa01200 | 1.01121632 |
64 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.00035507 |
65 | Circadian entrainment_Homo sapiens_hsa04713 | 0.99835443 |
66 | Olfactory transduction_Homo sapiens_hsa04740 | 0.97132776 |
67 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.97038950 |
68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.96240980 |
69 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.95861223 |
70 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.94900472 |
71 | Circadian rhythm_Homo sapiens_hsa04710 | 0.92487404 |
72 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.92155934 |
73 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.92050377 |
74 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.91117204 |
75 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.90593541 |
76 | Taste transduction_Homo sapiens_hsa04742 | 0.90345235 |
77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88029806 |
78 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.87878838 |
79 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.87801503 |
80 | Bile secretion_Homo sapiens_hsa04976 | 0.87005175 |
81 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.86753285 |
82 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.85957338 |
83 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.82901909 |
84 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.80337462 |
85 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.80196681 |
86 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.79877050 |
87 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.78942931 |
88 | Asthma_Homo sapiens_hsa05310 | 0.78603517 |
89 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.77103888 |
90 | ABC transporters_Homo sapiens_hsa02010 | 0.76648558 |
91 | Protein export_Homo sapiens_hsa03060 | 0.76635829 |
92 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.75493199 |
93 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.75061078 |
94 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.74208650 |
95 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.73897479 |
96 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70292989 |
97 | Long-term potentiation_Homo sapiens_hsa04720 | 0.68312284 |
98 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.68140096 |
99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.68080016 |
100 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.66099617 |
101 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.65895630 |
102 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.64279683 |
103 | Salivary secretion_Homo sapiens_hsa04970 | 0.62430242 |
104 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.61521980 |
105 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.61025613 |
106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60164011 |
107 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.59430454 |
108 | Renin secretion_Homo sapiens_hsa04924 | 0.57983345 |
109 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.56585041 |
110 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.55692744 |
111 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.55639424 |
112 | Huntingtons disease_Homo sapiens_hsa05016 | 0.51786786 |
113 | Insulin secretion_Homo sapiens_hsa04911 | 0.51584124 |
114 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.50497065 |
115 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.49198698 |
116 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.49095287 |
117 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47965284 |
118 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47520405 |
119 | Mineral absorption_Homo sapiens_hsa04978 | 0.45979084 |
120 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44525419 |
121 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43138866 |
122 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.42121052 |
123 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.39470304 |
124 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39455832 |
125 | RNA degradation_Homo sapiens_hsa03018 | 0.36458622 |
126 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.35910456 |
127 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32702081 |
128 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.32438226 |
129 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.32113349 |
130 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.31526151 |
131 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.30858234 |
132 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.30429144 |
133 | Long-term depression_Homo sapiens_hsa04730 | 0.29908308 |
134 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.29240123 |
135 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.29091665 |
136 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.29073736 |
137 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.27084862 |
138 | Phagosome_Homo sapiens_hsa04145 | 0.25607893 |
139 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.25514330 |
140 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.24024679 |
141 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.23679853 |
142 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.23585268 |
143 | Prion diseases_Homo sapiens_hsa05020 | 0.23567647 |